Liquidia Corp LQDA.OQ reported a quarterly adjusted loss of 49 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -37 cents. The mean expectation of nine analysts for the quarter was for a loss of 43 cents per share. Wall Street expected results to range from -55 cents to -35 cents per share.
Revenue rose 141.5% to $8.84 million from a year ago; analysts expected $4.04 million.
Liquidia Corp's reported EPS for the quarter was a loss of 49 cents.
The company reported a quarterly loss of $41.58 million.
Liquidia Corp shares had risen by 70.1% this quarter and gained 80.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 1% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"
Wall Street's median 12-month price target for Liquidia Corp is $32.00, about 33.8% above its last closing price of $21.20
This summary was machine generated from LSEG data August 12 at 01:30 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | -0.43 | -0.49 | Missed |
Mar. 31 2025 | -0.40 | -0.45 | Missed |
Dec. 31 2024 | -0.37 | -0.46 | Missed |
Sep. 30 2024 | -0.37 | -0.30 | Beat |